ODE (Office of Device Evaluation) adds third deputy director in reorganisation:
This article was originally published in Clinica
Executive Summary
A reorganisation is in store for the Office of Device Evaluation (ODE) at the US FDA's Center for Devices and Radiological Health now that Susan Alpert has left to work at the FDA's food centre. The agency is advertising for a third deputy director to assist the new director, who has not yet been appointed. Dr Alpert shared the oversight responsibilities for the centre's six review divisions with Kimber Richter, deputy director for science and regulatory policy. The other deputy, Phil Phillips, handled regulatory matters. By adding a second clinical deputy, CDRH director David Feigal aims to relieve the next ODE director of some of the workload. ODE is responsible for product reviews.